← Back to Search

CMR Imaging Techniques for Heart Disease (Myomapping Trial)

N/A
Recruiting
Led By Joseph U. Schoepf, MD
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject must be previously diagnosed with or suspected to have one of the following conditions: Myocardial ischemia or infarction (group 1), Hypertrophic cardiomyopathy (group 2), Infiltrative cardiomyopathy (group 3), Myocarditis (group 4).
Subject must be 18-90 years of age.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if a new MRI technique can help diagnose and treat patients with heart conditions.

Who is the study for?
This trial is for adults aged 18-90 with suspected or diagnosed heart conditions like ischemic heart disease, hypertrophic cardiomyopathy, infiltrative cardiomyopathy, or myocarditis. They must be referred for a CMR scan and can't participate if they have metal implants, acute psychiatric disorders, substance abuse issues, allergies to MRI contrast agents, are in an unstable condition or won't follow the study rules.
What is being tested?
The trial is testing advanced Cardiac Magnetic Resonance Imaging (CMR) techniques to better diagnose and monitor various heart diseases. It aims to see how well these new fast quantitative imaging methods work compared to traditional ones.
What are the potential side effects?
Since this trial involves imaging techniques rather than drugs, side effects may include discomfort during the procedure or reactions to contrast agents used in some MRIs such as mild allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have or might have a heart condition such as blocked arteries, thickened heart muscle, a disease causing heart tissue buildup, or inflammation of the heart muscle.
Select...
I am between 18 and 90 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Additional 5 minute research MR scan of heart.Experimental Treatment1 Intervention
The purpose of this is to evaluate new, faster MR scans

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
973 Previous Clinical Trials
7,399,144 Total Patients Enrolled
Joseph U. Schoepf, MDPrincipal InvestigatorMedical University of South Carolina
3 Previous Clinical Trials
299 Total Patients Enrolled

Media Library

Cardiac Magnetic Resonance (CMR) imaging techniques Clinical Trial Eligibility Overview. Trial Name: NCT02855554 — N/A
Heart disease Research Study Groups: Additional 5 minute research MR scan of heart.
Heart disease Clinical Trial 2023: Cardiac Magnetic Resonance (CMR) imaging techniques Highlights & Side Effects. Trial Name: NCT02855554 — N/A
Cardiac Magnetic Resonance (CMR) imaging techniques 2023 Treatment Timeline for Medical Study. Trial Name: NCT02855554 — N/A
~21 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top